Introducing QIAseq

QIAGEN Bioinformatics solutions – generate biological insights, not just data While NGS platforms produce millions of individual datapoints, analyzing, interpreting, and managing this data • Identification of new and known disease driver variants in hereditary diseases and cancer from in a standardized and reliable way is one of the major whole genome or exome challenges in the NGS workflow. QIAGEN Bioinformatics combines best-in-class NGS data • Analysis of targeted panels with clinical reports • Differential gene expression and whole transcriptome analysis and interpretation software with access to a unique analysis, including pathway analysis expert-curated knowledge base – for complete, optimized and streamlined end-to-end solutions: • Biomarker discovery through sample comparison • Species and function mapping in metagenomics • Epidemiological and outbreak analyses Oncology N S S O L U TI O Liquid biopsy S O L U T I O N S Support for all applications and user types SOLU TI O N S Biomarker discovery S N O I T U L O S Genetic diseases SOLUTI O N S Microbial isolate typing and metagenomics For up-to-date licensing information and product-specific disclaimers, see the respective QIAGEN kit handbook or user manual. QIAGEN kit handbooks and user manuals are available at www.qiagen.com or can be requested from QIAGEN Technical Services or your local distributor. Trademarks: QIAGEN®, Sample to Insight®, QIAcube®, QIAseq™, QIAsymphony®, QIAxcel®, QIAxpert®, PyroMark®, Pyrosequencing® (QIAGEN Group); Illumina® (Illumina, Inc); Ion Torrent™ (Life Technologies Corporation). Registered names, trademarks, etc. used in this document, even when not specifically marked as such, are not to be considered unprotected by law. PROM-10417-002 04/2017 © 2017 QIAGEN, all rights reserved. Ordering www.qiagen.com/shop Technical Support support.qiagen.com Website www.qiagen.com 1105619 04/2017

Pages Overview